FORMULATION DEVELOPMENT AND EVALUATION OF SUSTAINED RELEASE OXCARBAZEPINE TABLET

Journal Title: Journal of Drug Discovery and Therapeutics - Year 2015, Vol 3, Issue 8

Abstract

The Sustained release drug delivery systems that are designed to achieve or extend therapeutic effect by continuously releasing medication over an extended period of time after administration of a single dose, to individualize treatment more effectively. Oxcarbazepine indicated as monotherapy or adjunctive therapy for the treatment of partial seizures with or without secondarily generalized tonic-clonic seizures in adults and children. The polymer hydroxy propyl methyl cellulose (HPMC) was selected. The other excipients were used are magnesium stearate used as lubricant, Polyvinylpyrrolidone used as binder of tablet, and cross carmellose sodium as super disintegration agent. Oxcarbazepine was prepared by wet granulation technique.

Authors and Affiliations

Sinha Sonali| Mahatma Gandhi College of Pharmaceutical Sciences, Jaipur, Rajasthan, Goyal Kumar Anil| Mahatma Gandhi College of Pharmaceutical Sciences, Jaipur, Rajasthan, Satraval P. C. | Mahatma Gandhi College of Pharmaceutical Sciences, Jaipur, Rajasthan

Keywords

Related Articles

POMALIDOMIDE: A NOVEL PROMISING IMMUNOMODULATORY AGENT IN THE TREATMENT OF REFRACTORY AND RELAPSED MULTIPLE MYELOMA

Revival of thalidomide in the treatment of multiple myeloma (MM) has paved a path to search for compounds with increased antiangiogenic and anti-tumor effects, but decreased side-effects resulting in the development of t...

Quercetin Nanocrystal Formulation: In Vitro Anti-tumor Activity against Dalton Lymphoma Cells

In this present work quercetin nanocrystal (QNC) has been formulated and investigated its anti-tumor activity against Dalton’s lymphoma cells (DLA) in an in vitro model. Since quercetin has poor water solubility, it has...

EVALUATION OF PKD2 GENE (G/C) POLYMORPHISM IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE AMONG SOUTH INDIANS (MADURAI).

Polycystic kidney disease (PKD) is the leading causes of end-stage renal failure (ESRD) and a common indication of dialysis / renal transplantation. Autosomal dominant polycystic kidney disease (ADPKD) and autosomal rece...

A NOVAL TRANSDERMAL DRUG DELIVERY SYSTEM AND ITS POSSIBLE EVALUTATION: A REVIEW

A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. The human skin is a readily accessible surface for drug del...

FORMULATION AND EVALUATION OF IMMEDIATE RELEASE EMTRICITABINE & TENOFOVIR DISOPROXIL FUMARATE TABLET

The main purpose of the present study is to formulate and evaluate once daily an immediate release tablet of Emtricitabine and Tenofovir disproxil fumarate using different disintegrants. Preformulation studies were perfo...

Download PDF file
  • EP ID EP1657
  • DOI -
  • Views 547
  • Downloads 82

How To Cite

Sinha Sonali, Goyal Kumar Anil, Satraval P. C. (2015). FORMULATION DEVELOPMENT AND EVALUATION OF SUSTAINED RELEASE OXCARBAZEPINE TABLET. Journal of Drug Discovery and Therapeutics, 3(8), 41-61. https://europub.co.uk/articles/-A-1657